• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克隆性浆细胞的病理生理学和疾病的临床特征与系统性轻链淀粉样变性中克隆性浆细胞 cyclin D1 的表达有关。

Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis.

机构信息

Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.

出版信息

Clin Lymphoma Myeloma Leuk. 2012 Feb;12(1):49-58. doi: 10.1016/j.clml.2011.09.217. Epub 2011 Nov 18.

DOI:10.1016/j.clml.2011.09.217
PMID:22100494
Abstract

BACKGROUND

Overexpression of cyclin D1 (CCND1) in the clonal plasma cells (PCs) of patients with systemic light chain amyloidosis (AL) has been shown to occur even in cases without t(11;14). Associations between CCND1 expression and the clonal PC disease that underlies AL and the clinical features that characterize AL have not been systematically evaluated.

PATIENTS AND METHODS

To assess the significance of CCND1 expression in the pathophysiology of the clonal PC in AL, we evaluated CD138+ marrow PC from 16 newly diagnosed untreated patients by gene expression profiling (GEP) and performed a supervised analysis comparing clones that overexpressed CCND1 with those that did not. To assess the significance of CCND1 expression with respect to the clinical features of AL, we developed and validated a real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR) method for quantitating expression of CCND1 in the CD138+ marrow PC cells from 53 newly diagnosed cases of AL.

RESULTS

In the analysis of GEP data, clones that overexpressed CCND1 also expressed significantly higher levels of endoplasmic reticulum protein processing genes such as SEL1L, Sec63, and PDIA6. In the analysis of RT-qPCR data, patients whose clones overexpressed CCND1 more often made only free light chains and fewer intact M-proteins, and also had a lower response rate to initial therapy. In multivariate analysis, CCND1 expression was an independent baseline predictor of survival in AL.

CONCLUSION

CCND1 expression is a feature of the clonal PC disease in AL that merits prospective evaluation.

摘要

背景

系统性轻链淀粉样变性(AL)患者克隆浆细胞(PC)中 cyclin D1(CCND1)的过表达,即使在没有 t(11;14)的情况下也会发生。CCND1 表达与 AL 所基于的克隆 PC 疾病以及表征 AL 的临床特征之间的关联尚未系统评估。

患者和方法

为了评估 CCND1 表达在 AL 克隆 PC 病理生理学中的意义,我们通过基因表达谱(GEP)评估了 16 例新诊断未经治疗的患者的 CD138+骨髓 PC,并进行了一项有监督分析,比较了过表达 CCND1 的克隆与未过表达 CCND1 的克隆。为了评估 CCND1 表达与 AL 临床特征的意义,我们开发并验证了一种实时逆转录定量聚合酶链反应(RT-qPCR)方法,用于定量 53 例新诊断的 AL 患者的 CD138+骨髓 PC 细胞中 CCND1 的表达。

结果

在 GEP 数据分析中,过表达 CCND1 的克隆还表达了显著更高水平的内质网蛋白加工基因,如 SEL1L、Sec63 和 PDIA6。在 RT-qPCR 数据分析中,过表达 CCND1 的克隆的患者通常仅产生游离轻链且较少产生完整的 M 蛋白,并且初始治疗的反应率也较低。在多变量分析中,CCND1 表达是 AL 患者生存的独立基线预测因子。

结论

CCND1 表达是 AL 克隆 PC 疾病的一个特征,值得前瞻性评估。

相似文献

1
Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis.克隆性浆细胞的病理生理学和疾病的临床特征与系统性轻链淀粉样变性中克隆性浆细胞 cyclin D1 的表达有关。
Clin Lymphoma Myeloma Leuk. 2012 Feb;12(1):49-58. doi: 10.1016/j.clml.2011.09.217. Epub 2011 Nov 18.
2
Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis.克隆性浆细胞的功能基因表达分析确定了轻链淀粉样变性的独特分子特征。
Blood. 2005 Jan 15;105(2):794-803. doi: 10.1182/blood-2004-04-1424. Epub 2004 Sep 23.
3
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.轻链淀粉样变性中单克隆浆细胞的表型、转录组和基因组特征。
Blood. 2016 Jun 16;127(24):3035-9. doi: 10.1182/blood-2015-10-673095. Epub 2016 Apr 11.
4
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.在轻链淀粉样变性患者的克隆性浆细胞中检测到的新型复发性染色体畸变显示出潜在的不良预后影响:全基因组拷贝数阵列分析的初步结果
Haematologica. 2017 Jul;102(7):1281-1290. doi: 10.3324/haematol.2016.160721. Epub 2017 Mar 24.
5
Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan.系统性轻链(AL-)淀粉样变性患者克隆性浆细胞中钙网蛋白的表达与对大剂量美法仑的反应相关。
Blood. 2008 Jan 15;111(2):549-57. doi: 10.1182/blood-2007-05-090852. Epub 2007 Nov 2.
6
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis.基于流式细胞术对轻链淀粉样变性患者潜在克隆性B细胞和浆细胞的特征分析。
Cancer Med. 2016 Jul;5(7):1464-72. doi: 10.1002/cam4.725. Epub 2016 Apr 25.
7
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy.CD32B在系统性轻链淀粉样变性患者的克隆性浆细胞上高度表达,并为基于单克隆抗体的治疗提供了一个靶点。
Blood. 2008 Apr 1;111(7):3403-6. doi: 10.1182/blood-2007-11-125526. Epub 2008 Jan 23.
8
The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.原发性系统性淀粉样变性中器官受累的嗜性:Ig V(L) 种系基因使用和克隆性浆细胞负荷的作用。
Blood. 2001 Aug 1;98(3):714-20. doi: 10.1182/blood.v98.3.714.
9
Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.克隆性浆细胞转录异质性和免疫球蛋白轻链淀粉样变中的免疫逃逸。
Int J Hematol. 2021 Feb;113(2):231-242. doi: 10.1007/s12185-020-03016-3. Epub 2020 Oct 10.
10
Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation.克隆性免疫球蛋白轻链可变区种系基因在轻链型淀粉样变性中的应用:与主要淀粉样变性相关器官受累及干细胞移植后生存的关联
Br J Haematol. 1999 Sep;106(3):744-51. doi: 10.1046/j.1365-2141.1999.01591.x.

引用本文的文献

1
Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.60岁以上λ单克隆丙种球蛋白病患者系统性轻链淀粉样变性的筛查
J Clin Med. 2025 Jun 11;14(12):4146. doi: 10.3390/jcm14124146.
2
Heterohybridomas producing human immunoglobulin light chains using CD138-selected bone marrow cells.使用CD138筛选的骨髓细胞产生人免疫球蛋白轻链的异种杂交瘤。
Biochem Biophys Rep. 2025 Apr 23;42:102017. doi: 10.1016/j.bbrep.2025.102017. eCollection 2025 Jun.
3
The molecular landscape of AL amyloidosis.AL淀粉样变性的分子图谱。
Br J Haematol. 2025 May;206(5):1297-1311. doi: 10.1111/bjh.20070. Epub 2025 Apr 11.
4
Seeking Amyloidosis Very Early: Free light Chain Differentials and IGLV Gene Use as Screening Variables for Light-chain Amyloidosis in λ Monoclonal Gammopathies.极早期筛查淀粉样变性:游离轻链差异及IGLV基因使用作为λ单克隆丙种球蛋白病中轻链淀粉样变性的筛查变量
Br J Cancer Res. 2024 Jun;7(2):681-686. doi: 10.31488/bjcr.193. Epub 2024 May 23.
5
The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma.伴或不伴共存多发性骨髓瘤的轻链淀粉样变性的细胞遗传学异常图谱
J Clin Med. 2023 Feb 17;12(4):1624. doi: 10.3390/jcm12041624.
6
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: State-of-the-Art Review.AL型淀粉样变性:当前的化疗和免疫治疗策略:最新综述
JACC CardioOncol. 2021 Oct 19;3(4):467-487. doi: 10.1016/j.jaccao.2021.09.003. eCollection 2021 Oct.
7
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications.免疫球蛋白轻链淀粉样变性的遗传发病机制:基本特征及临床应用
Exp Hematol Oncol. 2021 Jul 20;10(1):43. doi: 10.1186/s40164-021-00236-z.
8
Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.克隆性浆细胞转录异质性和免疫球蛋白轻链淀粉样变中的免疫逃逸。
Int J Hematol. 2021 Feb;113(2):231-242. doi: 10.1007/s12185-020-03016-3. Epub 2020 Oct 10.
9
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.在轻链淀粉样变性患者的克隆性浆细胞中检测到的新型复发性染色体畸变显示出潜在的不良预后影响:全基因组拷贝数阵列分析的初步结果
Haematologica. 2017 Jul;102(7):1281-1290. doi: 10.3324/haematol.2016.160721. Epub 2017 Mar 24.
10
siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.靶向κ轻链恒定区的小干扰RNA:非纤维状和纤维状轻链沉积病治疗方法的临床前测试
Gene Ther. 2016 Oct;23(10):727-733. doi: 10.1038/gt.2016.50. Epub 2016 Jun 20.